http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112013004585-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c89ce4d9ac03f9acd8ddede1162f94d
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C211-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C211-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C211-25
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C209-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C211-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C211-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C211-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C211-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
filingDate 2011-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6044b1b3f940f9a2756aaeb01272f05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91224a4925413dac164105644d90e07a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_699a6cec1348628feb079b4648d5f086
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b90fa509bbccdad1fc13e100675c75b7
publicationDate 2016-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-112013004585-A2
titleOfInvention cationic lipid, lnp composition, and use of a cationic lipid
abstract cationic lipid, linp composition, and use of a cationic lipid. The present invention provides novel cationic lipids which may be used in combination with other lipid components, such as cholesterol and peg-lipids, to form lipid nanoparticles with oligonucleotides. It is an object of the present invention to provide a cationic lipid support that demonstrates improved efficiency associated with less liver toxicity due to lower liver lipid levels. The present invention employs low molecular weight cationic lipids with a short lipid chain to improve the efficiency and tolerability of in vivo distribution of rnasi.
priorityDate 2010-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507953
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5997

Total number of triples: 33.